| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $105.71 | $113.53B | N/A |
Is a Surprise Coming for Lilly (LLY) This Earnings Season?
http://www.zacks.com/stock/news/883574/is-a-surprise-coming-for-lilly-lly-this-earnings-season?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-883574
Apr 22, 2020 - Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
0
The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
http://www.zacks.com/stock/news/883840/the-zacks-analyst-blog-highlights-eli-lilly-dexcom-viewray-chemed-and-sage-therapeutics?cid=CS-ZC-FT-press_releases-883840
Apr 22, 2020 - The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
0
The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke
http://www.zacks.com/stock/news/883863/the-zacks-analyst-blog-highlights-exxon-mobil-oracle-eli-lilly-and-coke?cid=CS-ZC-FT-press_releases-883863
Apr 22, 2020 - The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke
0
Company News for Apr 24, 2020
http://www.zacks.com/stock/news/887485/company-news-for-apr-24-2020?cid=CS-ZC--corporate_summary-887485
Apr 24, 2020 - Companies In The News Are: LLY, SAVA, FLR, LYTS
0
Bayer (BAYRY) Q1 Earnings Beat Estimates, Sales Rise Y/Y
http://www.zacks.com/stock/news/891610/bayer-bayry-q1-earnings-beat-estimates-sales-rise-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-891610
Apr 27, 2020 - Bayer (BAYRY) beats earnings estimates for the first quarter of 2019.
0
Top Research Reports for Disney, Novo Nordisk & BHP
http://www.zacks.com/research-daily/1055128/top-research-reports-for-disney-novo-nordisk-bhp?cid=CS-ZC-FT-research_daily-1055128
Sep 08, 2020 - Top Research Reports for Disney, Novo Nordisk & BHP
0
AVEO Acquires Full Global Rights to Ficlatuzumab From Biodesix
http://www.zacks.com/stock/news/1055947/aveo-acquires-full-global-rights-to-ficlatuzumab-from-biodesix?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1055947
Sep 09, 2020 - AVEO reclaims complete rights to ficlatuzumab from Biodesix for an undisclosed sum. The candidate is being developed for several cancer indications.
0
No Econ Data, but Big Biopharma News
http://www.zacks.com/stock/news/1057905/no-econ-data-but-big-biopharma-news?cid=CS-ZC-FT-ahead_of_wall_street-1057905
Sep 14, 2020 - Merck, Gilead and Lilly make progress on an otherwise slow news day.
0
Stock Market News for Sep 15, 2020
http://www.zacks.com/stock/news/1058441/stock-market-news-for-sep-15-2020?cid=CS-ZC--market_news-1058441
Sep 15, 2020 - U.S. stock markets closed higher on Monday reversing some of the losses of the last week.
0
Roche's Actemra Meets Goal in Phase III Coronavirus Study
http://www.zacks.com/stock/news/1060395/roches-actemra-meets-goal-in-phase-iii-coronavirus-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1060395
Sep 18, 2020 - Roche's (RHHBY) phase III study, EMPACTA, evaluating Actemra in patients with COVID-19-associated pneumonia, meets primary endpoint.
0